Ex parte injunctions provide companies with urgent legal protection for intellectual property, allowing courts to issue orders without notifying the opposing party to prevent immediate harm. For trademark owners, these emergency measures are vital for stopping counterfeit goods or brand dilution before they spread, a risk often highlighted by brand dilution eroding value over time. A recent ruling by the Delhi High Court illustrates that courts demand absolute candor in exchange for such extraordinary relief. The cost of hiding material facts extends beyond the loss of an injunction to include significant financial penalties and a severe blow to credibility.
The Conflict Over Brand Identity
The dispute involved two pharmaceutical firms operating in the nutraceutical sector: Celagenex Research and Nugenesys Pharmaceuticals. Celagenex held the registered trademark NUREWIRE for Class 5 goods, while Nugenesys introduced a competing mark, RewireX, and began its commercial product launch.
Citing rights infringement, Celagenex approached the Delhi High Court seeking an ex parte ad interim injunction to stop Nugenesys from using the RewireX mark. The court initially granted this relief on May 20, 2026, authorizing local commissioners to seize products bearing the disputed label. However, the validity of this relief was subsequently questioned. The core issue shifted from the similarity of the marks to how Celagenex presented its case to the judiciary, reminiscent of legacy trademark disputes in the 21st century where identity and ownership are fiercely contested.
The Critical Role of Disclosure
In legal proceedings involving equitable remedies like injunctions, plaintiffs are required to approach the judiciary with total clarity and candor. This duty encompasses not only the immediate facts of the lawsuit but also requires the disclosure of all material events that might influence the court’s decision.
The Delhi High Court identified that Celagenex had suppressed critical information:
- Prior Awareness: Celagenex had sent a cease-and-desist notice to Nugenesys on October 29, 2025, objecting to the use of RewireX.
- Existing Proceedings: Celagenex had filed an opposition against Nugenesys’ trademark application with the Registrar of Trademarks in January 2026.
Despite initiating these actions months before seeking the injunction, Celagenex omitted them from its plaint. The company argued that because Nugenesys only began selling products in March 2026, earlier correspondence was irrelevant. The court rejected this logic. The suppression of prior legal steps misled the court regarding the timeline and nature of the dispute, preventing an informed decision on whether emergency relief was truly necessary.
A Pattern of Non-Disclosure
The judge’s criticism extended beyond this single case. Upon reviewing related files, the Division Bench identified a persistent pattern of suppression and non-disclosure by the legal counsel representing Celagenex across at least three different suits.
To illustrate the gravity of repeated misconduct, the court referenced Ian Fleming’s Goldfinger: "Once is happenstance. Twice is coincidence. Three times is enemy action." This analogy underscored a key legal principle: while a single error might be excused as an oversight, repeated failures to disclose material facts suggest a deliberate strategy rather than accident. When counsel habitually hides the true cause of action or prior proceedings to secure ex parte relief, they undermine the integrity of the judicial process. The court viewed this not merely as a procedural error but as an affront to the system itself.
Implications for Businesses and Trademark Owners
This ruling offers several crucial lessons for businesses managing their trademark portfolios:
- Ex Parte Relief is Discretionary: Courts are reluctant to grant emergency orders without notice to the other side, as this denies the defendant a chance to be heard. In exchange for this unilateral power, plaintiffs bear a heavier burden of proof and honesty.
- Full Chronology is Mandatory: When filing for an injunction, parties must disclose the entire history of the dispute, including prior cease-and-desist notices, oppositions, or negotiations with the opposing party. Hiding these details can lead to immediate dismissal of the application.
- Costs Can Be Painful: The Delhi High Court imposed costs of INR 200,000 on Celagenex for non-disclosure. This financial penalty serves as a deterrent, signaling that courts will punish bad faith behavior even without resulting in criminal charges.
- Public Interest Matters: The court evaluated whether public interest justified maintaining the injunction. Since there was no evidence that Nugenesys’ products were unsafe or substandard, continuing the ban would cause unnecessary commercial harm without protecting public health.
Moving Forward with Integrity
The vacating of the injunction and the release of seized products to Nugenesys highlights the judiciary’s commitment to fairness. The court noted that if Celagenex ultimately prevails in its case at trial, damages could provide an appropriate remedy. However, by attempting to secure emergency protection through ex parte relief while withholding facts, they forfeited their right to such interim measures.
For trademark lawyers and brand owners, the implication is clear: transparency is a strategic necessity, not just an ethical guideline. In intellectual property litigation, trust with the court is a valuable asset. Once that trust is broken through suppression or misrepresentation, even strong legal claims can be undermined before they are fully heard. This is particularly vital when navigating trademark law complexity and business strategy, where precise alignment between fact and representation is key to avoiding pitfalls like those faced by brands such as MARSO ROBOTICS or obnovity.